pTES: A New Electrical Approach to Pain

pTES: A New Electrical Approach to Fibromyalgia Pain

Most non-invasive brain stimulation techniques work by nudging neurons closer to their firing threshold — they make brain cells more likely to activate, but do not activate them directly. A September 2026 paper in Brain Stimulation describes a method designed to cross that line, and reports a small first test in people with fibromyalgia.

This is a nine-person feasibility pilot. It cannot show that the treatment works. What it does show is that the approach is tolerable and worth testing properly.

How pTES Differs

Pulsed transcranial electrical stimulation (pTES) delivers brief, high-amplitude electrical pulses through electrodes placed on the scalp. The amplitude is high enough to directly activate cortical neurons rather than merely priming them. The researchers targeted motor regions associated with the arm and leg.

A practical obstacle with this kind of stimulation is that it can sting. The team addressed it with a background train of low-level pulses, which they call "hums". On average, the hums reduced scalp discomfort by roughly two points on a 0-to-10 scale.

The Pilot Study

Nine participants with fibromyalgia received daily stimulation sessions across several weeks. Sham stimulation was delivered over the occipital area as a comparison. The team tracked pain sensitivity alongside how much fibromyalgia affected everyday activities, and focused primarily on feasibility and tolerability.

Key observations:

• Most participants tolerated stimulation at neuron-activating intensities.
• Reported side effects were temporary scalp discomfort, fatigue, and mild headaches.
• Stimulation reduced experimental pressure pain, which suggests the pulses engaged the brain's pain-relieving circuits.
• The background "hum" train measurably improved comfort.

What "Reduced Experimental Pressure Pain" Does Not Tell You

This phrase is easy to read as "it worked," and that reading is not supported. The measurement was of an experimentally induced pressure stimulus, tested in a handful of people, in a study not designed to detect a treatment effect. Reduced sensitivity to a laboratory pressure probe is a physiological signal about circuit engagement, not evidence that a patient's daily pain improves.

The authors are explicit about this. They describe the work as exploratory, note the sample is far too small to demonstrate efficacy, and state that larger controlled studies are needed to establish whether the effects are reliable, clinically meaningful, and lasting.

Who Ran It

The work is a collaboration between Carnegie Mellon University and the University of Pittsburgh. Jeehyun Kim, a biomedical engineering doctoral student at CMU, is lead author. The co-principal investigators are Dr. Ben Alter, an anesthesiologist at Pitt and Director of Translational Pain Research, and Pulkit Grover, professor of electrical and computer engineering at CMU.

The paper was accepted for publication in Brain Stimulation in September 2026.

Where This Fits

Fibromyalgia already has several non-invasive neuromodulation options under study, including transcranial direct current stimulation (tDCS), repetitive transcranial magnetic stimulation (rTMS), and non-invasive peripheral approaches such as TENS. pTES is mechanistically distinct because it aims to activate neurons directly rather than modulate their excitability.

Whether that distinction translates into better outcomes for patients is exactly what the next round of studies has to determine.